Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Underutilization of Guideline-Concordant Cardiac Screening among Patients with Cerebrovascular Disease

Sico J, Baye F, Myers L, Concato J, Williams LS, Bravata DM. Underutilization of Guideline-Concordant Cardiac Screening among Patients with Cerebrovascular Disease. [Abstract]. Stroke; A Journal of Cerebral Circulation. 2015 Apr 1; 46(4):AWP158.

Related HSR&D Project(s)




Abstract:

Introduction: Guidelines recommend the use of cardiac stress testing to screen for occult coronary heart disease (CHD) among patients with TIA and ischemic stroke who have a 'high risk' Framingham Risk score (FRS). It is unclear whether TIA/stroke patients regularly receive guideline-concordant cardiac stress testing. Methods: Administrative data from a sample of 10,923 Veterans from admitted to Veterans Health Administration (VHA) facilities with a TIA or mild stroke in fiscal year 2011 were analyzed. Patients were excluded (n = 6947) on the basis of a history of CHD, receipt of cardiac stress testing within 18-months prior to cerebrovascular event, patients who died within 90 days of discharge or were discharged to hospice, and those with missing/unknown race. A FRS was calculated for each patient based on: age, gender, race, systolic blood pressure, blood pressure treatment (yes/no), diabetes, smoking status (smoker/non-smoker), and cholesterol (total and high-density lipoprotein). Patients with an FRS 20 were classified as 'high risk' of having CHD. Administrative data were used to identify whether cardiac stress testing was performed within 6-months after the cerebrovascular event. Results: Of the 3976 TIA/mild stroke patients, 53.9% (2322) had FRS 20. A higher proportion of patients with FRS 20 that received cardiac screening were younger, white men with diabetes and without a history of cancer, compared with patients with a FRS 20 that did not receive testing. Cardiac stress testing was not performed more frequently for 'high risk' (4.5%; 104/2322) versus 'low/intermediate risk' (4.7%; 77/1654) FRS (OR = 0.96; CI95:071-1.30). Conclusions: Guideline concordant cardiac screening is underutilized among patients with TIA and minor ischemic stroke. Additional research is required to: 1) better understand clinicians' understanding of and approach to cardiac screening for patients with cerebrovascular disease at high risk for CHD; and 2) determine whether cardiac screening improves post-TIA/stroke outcomes.





Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.